Interleukin 6 gene polymorphisms are associated with systemic lupus erythematosus in Koreans

Journal of Rheumatology

Volumn 37, Issue 11, 2010, Pages 2251-2258

  Jeon, Ja Young ^a   Kim, Hyoun Ah ^a   Kim, Seung Hyun ^a   Park, Hae Sim ^a   Suh, Chang Hee ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Interleukin 6; Promoter; Single nucleotide polymorphism; Systemic lupus erythematosus

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; ASIAN; CELL STRAIN; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXON; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; HAPLOTYPE; HELA CELL; HEP3B CELL; HUMAN; HYPOCOMPLEMENTEMIA; KOREAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

ADULT; ALLELES; ANALYSIS OF VARIANCE; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-6; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 78149237751     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100170     Document Type: Article

References (36)

1. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol 2003;56:481-90.
2. Deapen D, Escalante A, Weinrib L, Horwitz D, Bachman B, Roy-Burman P, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992;35:311-8.
3. Reichlin M, Harley JB, Lockshin MD. Serologic studies of monozygotic twins with systemic lupus erythematosus. Arthritis Rheum 1992;35:457-64.
4. Tsao BP. The genetics of human systemic lupus erythematosus. Trends Immunol 2003;24:595-602. (Pubitemid 37338528)
5. Croker JA, Kimberly RP. Genetics of susceptibility and severity in systemic lupus erythematosus. Curr Opin Rheumatol 2005;17:529-37.
6. Naka T, Nishimoto N, Kishimoto T. The paradigm of IL6: from basic science to medicine. Arthritis Res 2002;4 Suppl 3:S233-42.
7. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127-37.
8. Dean GS, Tyrrell-Price J, Crawley E, Isenberg DA. Cytokines and systemic lupus erythematosus. Ann Rheum Dis 2000;59:243-51.
9. Tsokos GC, Kovacs B, Liossis SN. Lymphocytes, cytokines, inflammation, and immune trafficking. Curr Opin Rheumatol 1997;9:380-6.
10. Suh CH, Kim HA. Cytokines and their receptors as biomarkers of systemic lupus erythematosus. Expert Rev Mol Diagn 2008;8:189-98.
11. Chun HY, Chung JW, Kim HA, Yun JM, Jeon JY, Ye YM, et al. Cytokine IL6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol 2007;27:461-6.
12. Pascual M, Nieto A, Mataran L, Balsa A, Pascual-Salcedo D, Martin J. IL6 promoter polymorphisms in rheumatoid arthritis. Genes Immun 2000;1:338-40.
13. Vozarova B, Fernandez-Real JM, Knowler WC, Gallart L, Hanson RL, Gruber JD, et al. The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Hum Genet 2003;112:409-13.
14. Georges JL, Loukaci V, Poirier O, Evans A, Luc G, Arveiler D, et al. Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J Mol Med 2001;79:300-5.
15. Faltraco F, Burger K, Zill P, Teipel SJ, Moller HJ, Hampel H, et al. Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk. J Am Geriatr Soc 2003;51:578-9. (Pubitemid 36457367)
16. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, et al. The effect of novel polymorphisms in the interleukin-6 (IL6) gene on IL6 transcription and plasma IL6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76. (Pubitemid 28467565)
17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
18. Nath SK, Kilpatrick J, Harley JB. Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 2004;16:794-800. (Pubitemid 39423671)
19. Rhodes B, Vyse TJ. General aspects of the genetics of SLE. Autoimmunity 2007;40:550-9.
20. Tsao BP. Genetic susceptibility to lupus nephritis. Lupus 1998;7:585-90.
21. Schotte H, Schluter B, Rust S, Assmann G, Domschke W, Gaubitz M. Interleukin-6 promoter polymorphism (-174 G/C) in Caucasian German patients with systemic lupus erythematosus. Rheumatology 2001;40:393-400. (Pubitemid 32409550)
22. Linker-Israeli M, Honda M, Nand R, Mandyam R, Mengesha E, Wallace DJ, et al. Exogenous IL-10 and IL-4 down-regulate IL6 production by SLE-derived PBMC. Clin Immunol 1999;91:6-16.
23. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000;275:18138-44. (Pubitemid 30414764)
24. Faggioli L, Costanzo C, Donadelli M, Palmieri M. Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun. Biochim Biophys Acta 2004;1692:17-24. (Pubitemid 38670257)
25. Baccam M, Woo SY, Vinson C, Bishop GA. CD40-mediated transcriptional regulation of the IL6 gene in B lymphocytes: involvement of NF-kappa B, AP-1, and C/EBP. J Immunol 2003;170:3099-108. (Pubitemid 36302185)
26. Tuyt LM, Dokter WH, Birkenkamp K, Koopmans SB, Lummen C, Kruijer W, et al. Extracellular-regulated kinase 1/2, Jun N-terminal kinase, and c-Jun are involved in NF-kappa B-dependent IL6 expression in human monocytes. J Immunol 1999;162:4893-902.
27. Grassl C, Luckow B, Schlondorff D, Dendorfer U. Transcriptional regulation of the interleukin-6 gene in mesangial cells. J Am Soc Nephrol 1999;10:1466-77.
28. Mann J, Oakley F, Johnson PW, Mann DA. CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-kappa B, AND CBF1. J Biol Chem 2002;277:17125-38.
29. Persson E, Voznesensky OS, Huang YF, Lerner UH. Increased expression of interleukin-6 by vasoactive intestinal peptide is associated with regulation of CREB, AP-1 and C/EBP, but not NF-kappaB, in mouse calvarial osteoblasts. Bone 2005;37:513-29.
30. Kelberman D, Fife M, Rockman MV, Brull DJ, Woo P, Humphries SE. Analysis of common IL6 promoter SNP variants and the AnTn tract in humans and primates and effects on plasma IL6 levels following coronary artery bypass graft surgery. Biochim Biophys Acta 2004;1688:160-7.
31. Linker-Israeli M, Wallace DJ, Prehn J, Michael D, Honda M, Taylor KD, et al. Association of IL6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL6 expression. Genes Immun 1999;1:45-52.
32. Zhai R, Liu G, Yang C, Huang C, Wu C, Christiani DC. The G to C polymorphism at -174 of the interleukin-6 gene is rare in a Southern Chinese population. Pharmacogenetics 2001;11:699-701.
33. Nakajima T, Ota N, Yoshida H, Watanabe S, Suzuki T, Emi M. Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women. Genes Immun 1999;1:115-9.
34. Lim CS, Zheng S, Kim YS, Ahn C, Han JS, Kim S, et al. The -174 G to C polymorphism of interleukin-6 gene is very rare in Koreans. Cytokine 2002;19:52-4.
35. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics 1987;117:331-41.
36. Maruyama T. Stochastic integrals and their application to population genetics. In: Kimura M, ed. Molecular evolution, protein polymorphism and the neutral theory. Berlin: Springer-Verlag; 1982:151-66.